GeneNews Provides Update on GEM and Alumina Financings
Oct 03, 2016 12:01 pm UTC| Business
TORONTO, Oct. 03, 2016 -- Further to its press releases issued on April 28, June 9 and July 26, 2016, GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) provided an update today on its financing activities. ...
INC Research Announces Executive Leadership Promotions
Oct 03, 2016 12:01 pm UTC| Business
RALEIGH, N.C., Oct. 03, 2016 -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the promotions of Michael Gibertini, PhD, and Tara Fitzgerald to...
ChinaCache to Participate in Jefferies 6th Annual Greater China Summit
Oct 03, 2016 12:01 pm UTC| Business
BEIJING, Oct. 03, 2016 -- ChinaCache International Holdings Ltd. ("ChinaCache" or the "Company") (NASDAQ:CCIH), the leading total solutions provider of Internet content and application delivery services in China, today...
Oct 03, 2016 12:01 pm UTC| Business
NEW YORK, Oct. 03, 2016 -- Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech (NASDAQ:FBIO) company, today announced that the first patient has been dosed in a Phase 1/2 clinical study of CK-101, its...
K2M Group Holdings, Inc. to Release Third Quarter 2016 Financial Results on November 2nd
Oct 03, 2016 12:01 pm UTC| Business
LEESBURG, Va., Oct. 03, 2016 -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex...
BroadSoft Technology Integrated in One Talk℠ by Verizon: First U.S. Business 4G VoLTE Offering
Oct 03, 2016 12:01 pm UTC| Business
GAITHERSBURG, Md., Oct. 03, 2016 -- BroadSoft, Inc. (NASDAQ:BSFT), a global unified communication software as a service (UCaaS) leader, today announced that its BroadWorks® platform is integrated in One Talk by Verizon...
Argos Therapeutics to Participate in 2016 Cell & Gene Meeting on the Mesa
Oct 03, 2016 12:01 pm UTC| Business
DURHAM, N.C., Oct. 03, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of truly individualized immunotherapies based on the Arcelis®...